*Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy;
†Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel;
‡Department of Ophthalmology, University Eye Hospital in Ljubljana, Slovenia;
§Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom; and
¶UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Reprint requests: Alessandro Arrigo, MD, Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, via Olgettina 60, Milan 20132, Italy; e-mail: [email protected]
Francesco Bandello consultant for: Alcon (Fort Worth, TX), Alimera Sciences (Alpharetta, GA), Allergan Inc (Irvine, CA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering Pharma (Berlin, Germany), Bausch & Lomb (Rochester, NY), Genentech (San Francisco, CA), Hoffmann-La Roche (Basel, Switzerland), Novagali Pharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), ThromboGenics (Heverlee, Belgium), and Zeiss (Dublin). The remaining authors have any financial/conflicting interests to disclose.